Upregulation of CoQ shifts ferroptosis dependence from GPX4 to FSP1 in acquired radioresistance-Reference-Cited by-同舟云学术

Upregulation of CoQ shifts ferroptosis dependence from GPX4 to FSP1 in acquired radioresistance

Published:2024-03 Issue: Volume:73 Page:101032
ISSN:1368-7646
Container-title:Drug Resistance Updates
language:en
Short-container-title:Drug Resistance Updates

Author:

Lin Xu,Zhang Qingyi,Li Qi,Deng Jun,Shen Shuying,Tang Muhu,Ye Xianghua,Ji Cong,Yang Yuhong,Chen Yuxiao,Zeng Liping,Zhao Jiangang,Kouwenhoven M.B.N.,Lucero-Prisno Don Eliseo,Huang Junjie,Li Yangling,Zhang Bo,Hu Jian

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Cancer Research,Pharmacology,Oncology

Reference59 articles.

1. Safety and efficacy of statin therapy;Adhyaru;Nat. Rev. Cardiol.,2018

2. Statin use is associated with better prognosis of patients with prostate cancer after definite therapies: a systematic review and meta-analysis of cohort studies;An;J. Oncol.,2022

3. ADCK3/COQ8A: the choice target of the UbiB protein kinase-like family;Asquith;Nat. Rev. Drug Discov.,2019

4. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis;Bersuker;Nature,2019

5. Repurposing statin drugs to decrease toxicity and improve survival outcomes in head and neck cancer;Bourguillon;OTO Open,2021

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanomedicines Targeting Ferroptosis to Treat Stress-Related Diseases;International Journal of Nanomedicine;2024-08

2. Unveiling the role of ferroptosis in the progression from NAFLD to NASH: recent advances in mechanistic understanding;Frontiers in Endocrinology;2024-07-04

3. Ferroptosis in ulcerative colitis: Potential mechanisms and promising therapeutic targets;Biomedicine & Pharmacotherapy;2024-06

4. Recent advancements in nanomaterial-mediated ferroptosis-induced cancer therapy: Importance of molecular dynamics and novel strategies;Life Sciences;2024-06